Radiopharm Theranostics CEO and Managing Director Riccardo Canevari, Chief Medical Officer Dr. David Mozley, and Executive Chairman Paul Hopper joined.
Radiopharm Theranostics Ltd (ASX:RAD) has agreed commercial terms for services in a signed Letter of Intent (LOI) with global oncology provider GenesisCare,.
Radiopharm Theranostics Ltd beefs up executive team ahead of roadshow and steams ahead with pipeline development proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Overseas CEOs from Chimeric Therapeutics, BCAL Diagnostics and Radiopharm Theranostics are fronting local investors, hoping to shore up support amid the sell-off.